Contact this trialFirst, we need to learn more about you.
Alkylating agents
Combination Chemotherapy for Ewing Sarcoma
Recruiting2 awardsPhase 3
Miami, Florida
This trial found that adding the new chemotherapy drug combination to the established treatment approach improved the outcome for patients with extracranial Ewing sarcoma.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.